![XS2592804434 - Teva Pharmaceutical Finance Netherlands II BV Aktien - Aktienkurs, Institutioneller Eigentümerschaft, Aktionäre XS2592804434 - Teva Pharmaceutical Finance Netherlands II BV Aktien - Aktienkurs, Institutioneller Eigentümerschaft, Aktionäre](https://images.fintel.io/nl-xs2592804434-so.png)
XS2592804434 - Teva Pharmaceutical Finance Netherlands II BV Aktien - Aktienkurs, Institutioneller Eigentümerschaft, Aktionäre
![TEVJF - Teva- Pharmaceutical Industries Ltd. Aktien - Aktienkurs, Institutioneller Eigentümerschaft, Aktionäre (OTC) TEVJF - Teva- Pharmaceutical Industries Ltd. Aktien - Aktienkurs, Institutioneller Eigentümerschaft, Aktionäre (OTC)](https://images.fintel.io/us-tevjf-so.png)
TEVJF - Teva- Pharmaceutical Industries Ltd. Aktien - Aktienkurs, Institutioneller Eigentümerschaft, Aktionäre (OTC)
![MedinCell's Partner Teva Provides Guidance for UZEDY in 2024 and an Update on the Treatment-Candidate of Olanzapine Long-Acting Injectable (LAI) MedinCell's Partner Teva Provides Guidance for UZEDY in 2024 and an Update on the Treatment-Candidate of Olanzapine Long-Acting Injectable (LAI)](https://www.finanznachrichten.de/chart-teva-pharmaceutical-industries-ltd-aktie-1jahrklein-tradegate.png)
MedinCell's Partner Teva Provides Guidance for UZEDY in 2024 and an Update on the Treatment-Candidate of Olanzapine Long-Acting Injectable (LAI)
![Teva Pharmaceutical Industries Limited: New Post Hoc Phase 3 Data Analysis Shows AJOVY (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity Teva Pharmaceutical Industries Limited: New Post Hoc Phase 3 Data Analysis Shows AJOVY (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity](https://www.finanznachrichten.de/chart-teva-pharmaceutical-industries-ltd-aktie-intraday-tradegate.png)